Similarly to non-GLP-1 patients, combined strength and cardio training are more effective for weight loss than strength or cardio alone
Determining whether it is related to a specific drug versus weight change, nutrition, or other factors requires clinical evaluation and patient-specific context
By achieving unprecedented efficacy in weight loss, glycemic control, and cardiovascular outcomes, semaglutide demonstrated the full potential of GLP-1 receptor activation while highlighting the limitations of monoreceptor therapynamely, variable interindividual response, plateauing efficacy, and dose-related GI intolerance
We try to get you to a lower dose where your weight is stable, youre not gaining weight back and youre continuing to benefit from the effects of these medications, says Dr
They felt fuller and had fewer hunger pangs